Database of the clinical phenotypes, genotypes and mutant arylsulfatase B structures in mucopolysaccharidosis type VI

被引:0
|
作者
Seiji Saito
Kazuki Ohno
Masakazu Sekijima
Toshihiro Suzuki
Hitoshi Sakuraba
机构
[1] Hokkaido Information University,Department of Medical Management and Informatics
[2] NPO for the Promotion of Research on Intellectual Property Tokyo,Department of Analytical Biochemistry
[3] Global Scientific Information and Computing Center,Department of Clinical Genetics
[4] Tokyo Institute of Technology,undefined
[5] Meiji Pharmaceutical University,undefined
[6] Meiji Pharmaceutical University,undefined
[7] 6Current address: Drug Discovery Research,undefined
[8] Astellas Pharma Inc.,undefined
[9] Tsukuba,undefined
[10] Ibaraki,undefined
[11] Japan.,undefined
来源
Journal of Human Genetics | 2012年 / 57卷
关键词
amino acid substitution; arylsulfatase B; database; mucopolysaccharidosis type VI; protein structure;
D O I
暂无
中图分类号
学科分类号
摘要
Mucopolysaccharidosis type VI (MPS VI) is a genetic disorder caused by a deficiency of arylsulfatase B (ARSB). In our previous study, we investigated the structural changes in ARSB caused by amino acid substitutions associated with MPS VI, and revealed that such structural changes in ARSB were correlated with the clinical phenotypes. To the best of our knowledge, there is no database containing the structures of mutant ARSBs. Here, we built a database of clinical phenotypes, genotypes and structures of mutant ARSBs (http://mps6-database.org). This database can be accessed via the Internet, and is user friendly being equipped with powerful computational tools. This database will be useful for a better understanding of MPS VI.
引用
收藏
页码:280 / 282
页数:2
相关论文
共 50 条
  • [1] Database of the clinical phenotypes, genotypes and mutant arylsulfatase B structures in mucopolysaccharidosis type VI
    Saito, Seiji
    Ohno, Kazuki
    Sekijima, Masakazu
    Suzuki, Toshihiro
    Sakuraba, Hitoshi
    JOURNAL OF HUMAN GENETICS, 2012, 57 (04) : 280 - 282
  • [2] Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase
    Marion M Brands
    Marianne Hoogeveen-Westerveld
    Marian A Kroos
    Willemieke Nobel
    George J Ruijter
    Lale Özkan
    Iris Plug
    Daniel Grinberg
    Lluïsa Vilageliu
    Dicky J Halley
    Ans T van der Ploeg
    Arnold J Reuser
    Orphanet Journal of Rare Diseases, 8
  • [3] Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase
    Brands, Marion M.
    Hoogeveen-Westerveld, Marianne
    Kroos, Marian A.
    Nobel, Willemieke
    Ruijter, George J.
    Ozkan, Lale
    Plug, Iris
    Grinberg, Daniel
    Vilageliu, Lluisa
    Halley, Dicky J.
    van der Ploeg, Ans T.
    Reuser, Arnold J.
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [4] Fabry-database.org: database of the clinical phenotypes, genotypes and mutant α-galactosidase A structures in Fabry disease
    Seiji Saito
    Kazuki Ohno
    Hitoshi Sakuraba
    Journal of Human Genetics, 2011, 56 : 467 - 468
  • [5] Fabry-database.org: database of the clinical phenotypes, genotypes and mutant α-galactosidase A structures in Fabry disease
    Saito, Seiji
    Ohno, Kazuki
    Sakuraba, Hitoshi
    JOURNAL OF HUMAN GENETICS, 2011, 56 (06) : 467 - 468
  • [6] MAROTEAUX-LAMY MUCOPOLYSACCHARIDOSIS (TYPE-VI) AND ARYLSULFATASE B DEFICIENCY
    DIFERRAN.N
    SINGH, J
    DONNELLY, PV
    GNIOTSZU.J
    FEDERATION PROCEEDINGS, 1974, 33 (05) : 1520 - 1520
  • [7] Identification of mutations in the arylsulfatase B gene in Russian patients with type VI mucopolysaccharidosis
    Voskoboeva, EY
    Krasnopolskaya, XD
    Peters, K
    von Figura, K
    RUSSIAN JOURNAL OF GENETICS, 2000, 36 (06) : 689 - 694
  • [8] A NOVEL ARYLSULFATASE B MUTATION IN A PATIENT WITH MUCOPOLYSACCHARIDOSIS TYPE VI MISDIAGNOSED AS AUSTIN SYNDROME
    Hasadsri, Linda
    Raymond, Kimiyo
    Sanders, Karen
    Lacey, Jean
    Wood, Timothy C.
    King, Kellie
    Pichurin, Pavel N.
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (03) : 266 - 266
  • [9] Identification of arylsulfatase B gene mutations and clinical presentations of Iranian patients with Mucopolysaccharidosis VI
    Aminzadeh, Majid
    Malekpour, Nasrin
    Ghandil, Pegah
    GENE, 2019, 706 : 1 - 5
  • [10] In Vitro and In Vivo Characterization of an Engineered Arylsulfatase B for Therapy of Mucopolysaccharidosis VI
    Ferla, Rita
    Claudiani, Pamela
    Cotugno, Gabriella
    Petrey, Aaron
    Steet, Richard
    Auricchio, Alberto
    MOLECULAR THERAPY, 2013, 21 : S138 - S138